Ceftazidime-related nonconvulsive status epilepticus

A. D. Klion, J. Kallsen, C. T. Cowl, W. M. Nauseef

Research output: Contribution to journalArticle

36 Scopus citations


The third-generation cephalosporin, ceftazidime, is widely used for the treatment of serious gram-negative infections. As is true of cephalosporins in general, reported adverse effects have been few. We report a case of ceftazidime-induced status epilepticus in a patient with Pseudomonas aeruginosa meningitis and compare the clinical manifestations of this case with those of two previously described cases of ceftazidime-related encephalopathy. This diagnosis should be entertained and an electroencephalogram should be obtained in all patients with myoclonus and/or altered mental status while they are receiving ceftazidime therapy.

Original languageEnglish (US)
Pages (from-to)586-589
Number of pages4
JournalArchives of internal medicine
Issue number5
StatePublished - Apr 19 1994


ASJC Scopus subject areas

  • Internal Medicine

Cite this

Klion, A. D., Kallsen, J., Cowl, C. T., & Nauseef, W. M. (1994). Ceftazidime-related nonconvulsive status epilepticus. Archives of internal medicine, 154(5), 586-589. https://doi.org/10.1001/archinte.154.5.586